Xiaodong Jiao Selected Research

Indicators and Reagents (Reagents)

5/2018

ADAM-17 is a poor prognostic indicator for patients with hilar cholangiocarcinoma and is regulated by FoxM1.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiaodong Jiao Research Topics

Disease

9	Neoplasms (Cancer) 01/2024 - 06/2013
5	Cataract (Cataracts) 01/2023 - 01/2017
2	Colorectal Neoplasms (Colorectal Cancer) 03/2024 - 01/2019
2	Myopia 01/2023 - 04/2009
2	Retinitis Pigmentosa (Pigmentary Retinopathy) 01/2018 - 01/2018
2	Stomach Neoplasms (Stomach Cancer) 05/2015 - 06/2013
1	Duodenal Neoplasms (Duodenal Cancer) 03/2024
1	Circulating Neoplastic Cells 10/2023
1	Familial ectopia lentis 01/2023
1	type 1 Stickler syndrome 01/2023
1	Atrophy 01/2023
1	Glaucoma 01/2023
1	Inflammation (Inflammations) 01/2023
1	Eye Diseases (Eye Disease) 12/2022
1	Peroxisomal Disorders (Peroxisomal Disorder) 04/2021
1	Adenocarcinoma 01/2021
1	Neoplasm Metastasis (Metastasis) 01/2021
1	Chronic Pancreatitis 01/2021
1	Carcinogenesis 01/2019
1	Klatskin Tumor 05/2018
1	Leber Congenital Amaurosis 01/2014
1	Cone-Rod Dystrophies 01/2014
1	Alopecia (Baldness) 10/2012
1	Stomatitis 10/2012
1	Neutropenia 10/2012
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2012
1	Lung Neoplasms (Lung Cancer) 10/2012
1	Open-Angle Glaucoma (Glaucoma, Open Angle) 01/2012
1	congenital stationary Night blindness 10/2010
1	Oculocutaneous Albinism (Albinism, Yellow Mutant) 09/2007
1	Hypopigmentation (Hypomelanosis) 09/2007
1	Vision Disorders (Hemeralopia) 01/2007
1	Macular Degeneration (Age-Related Maculopathy) 06/2006

Drug/Important Bio-Agent (IBA)

2	Transcription Factors (Transcription Factor)IBA 03/2024 - 12/2022
2	Retinaldehyde (Retinal)IBA 01/2023 - 10/2010
2	Proteins (Proteins, Gene)FDA Link 04/2021 - 06/2013
2	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 04/2009
2	Messenger RNA (mRNA)IBA 05/2018 - 01/2018
1	StreptavidinIBA 03/2024
1	ErbB Receptors (EGF Receptor)IBA 01/2024
1	Epidermal Growth Factor (EGF)IBA 01/2024
1	N- (1,2,3,5,6,7- hexahydro- S- indacen- 4- ylcarbamoyl)- 4- (2- hydroxy- 2- propanyl)- 2- furansulfonamideIBA 01/2023
1	ethanoxyhexamercarbideIBA 01/2023
1	SRT1720IBA 01/2023
1	Fibrillin-1IBA 01/2023
1	Carrier Proteins (Binding Protein)IBA 01/2023
1	Glucose (Dextrose)FDA LinkGeneric 01/2023
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2023
1	Sirtuin 1IBA 01/2023
1	InflammasomesIBA 01/2023
1	Crystallins (Crystallin)IBA 12/2022
1	AntioxidantsIBA 12/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	MicroRNAs (MicroRNA)IBA 01/2021
1	AntigensIBA 01/2019
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2019
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2019
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2018
1	Indicators and Reagents (Reagents)IBA 05/2018
1	ADAM17 ProteinIBA 05/2018
1	lecithin-retinol acyltransferaseIBA 01/2018
1	Chloride Channels (Chloride Channel)IBA 01/2018
1	C 541IBA 01/2018
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2017
1	Cisplatin (Platino)FDA LinkGeneric 05/2015
1	Metformin (Glucophage)FDA LinkGeneric 05/2015
1	Sirolimus (Rapamycin)FDA Link 05/2015
1	aryl hydrocarbon receptor-interacting proteinIBA 01/2014
1	Pemetrexed (MTA)FDA Link 10/2012
1	Docetaxel (Taxotere)FDA Link 10/2012
1	betaglycan (TGFBR3)IBA 01/2012
1	LumicanIBA 04/2009
1	cyclo(5- hydroxytryptophyl- 5- hydroxytryptophyl)IBA 09/2007
1	Complement Factor H (Factor H)IBA 06/2006

Therapy/Procedure

5	Therapeutics 03/2024 - 10/2012
2	Lenses 01/2023 - 12/2021
1	Caloric Restriction 12/2021
1	Slit Lamp 12/2021
1	Corneal Transplantation (Keratoplasty) 01/2007